Cozad Asset Management Inc. reduced its stake in Clorox Co (NYSE:CLX) by 0.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,664 shares of the company’s stock after selling 77 shares during the period. Cozad Asset Management Inc.’s holdings in Clorox were worth $1,952,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of the company. Morgan Stanley boosted its position in Clorox by 178.2% during the 3rd quarter. Morgan Stanley now owns 3,063,813 shares of the company’s stock worth $460,828,000 after buying an additional 1,962,433 shares during the period. Schroder Investment Management Group increased its stake in Clorox by 57.0% during the 2nd quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock valued at $201,641,000 after purchasing an additional 547,070 shares in the last quarter. FMR LLC increased its stake in Clorox by 201.0% during the 2nd quarter. FMR LLC now owns 472,179 shares of the company’s stock valued at $63,863,000 after purchasing an additional 315,298 shares in the last quarter. DekaBank Deutsche Girozentrale increased its stake in Clorox by 110.5% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 427,013 shares of the company’s stock valued at $61,991,000 after purchasing an additional 224,143 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its stake in Clorox by 15.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,664,803 shares of the company’s stock valued at $250,403,000 after purchasing an additional 218,364 shares in the last quarter. Institutional investors own 77.73% of the company’s stock.
CLX has been the subject of a number of recent research reports. Atlantic Securities initiated coverage on shares of Clorox in a research note on Thursday, September 20th. They set a “neutral” rating and a $151.00 price target for the company. ValuEngine raised shares of Clorox from a “hold” rating to a “buy” rating in a report on Saturday, September 22nd. Argus raised shares of Clorox from a “hold” rating to a “buy” rating and set a $175.00 price target on the stock in a report on Tuesday, September 25th. Zacks Investment Research raised shares of Clorox from a “hold” rating to a “buy” rating and set a $171.00 price target on the stock in a report on Wednesday, October 3rd. Finally, Barclays set a $131.00 price target on shares of Clorox and gave the stock a “hold” rating in a report on Saturday, October 6th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $148.08.
Shares of CLX stock traded down $2.72 during trading on Monday, hitting $150.63. The company had a trading volume of 47,688 shares, compared to its average volume of 1,317,442. The company has a current ratio of 1.07, a quick ratio of 0.65 and a debt-to-equity ratio of 3.38. The stock has a market cap of $19.27 billion, a price-to-earnings ratio of 24.08, a price-to-earnings-growth ratio of 3.77 and a beta of 0.39. Clorox Co has a 52 week low of $113.57 and a 52 week high of $167.70.
Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.59 by $0.03. The company had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.53 billion. Clorox had a net margin of 13.59% and a return on equity of 102.65%. Clorox’s revenue for the quarter was up 4.2% compared to the same quarter last year. During the same period in the prior year, the business earned $1.46 earnings per share. As a group, sell-side analysts forecast that Clorox Co will post 6.31 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, February 8th. Shareholders of record on Wednesday, January 23rd will be paid a $0.96 dividend. This represents a $3.84 annualized dividend and a yield of 2.55%. The ex-dividend date is Tuesday, January 22nd. Clorox’s dividend payout ratio is currently 61.34%.
In other Clorox news, SVP Diego J. Barral sold 12,880 shares of the company’s stock in a transaction that occurred on Tuesday, November 6th. The stock was sold at an average price of $157.98, for a total value of $2,034,782.40. Following the completion of the sale, the senior vice president now owns 18,603 shares of the company’s stock, valued at $2,938,901.94. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Dawn C. Willoughby sold 54,205 shares of the company’s stock in a transaction that occurred on Tuesday, November 6th. The stock was sold at an average price of $157.39, for a total value of $8,531,324.95. Following the completion of the sale, the chief operating officer now directly owns 37,044 shares of the company’s stock, valued at approximately $5,830,355.16. The disclosure for this sale can be found here. In the last ninety days, insiders sold 313,228 shares of company stock valued at $50,910,506. 1.40% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: This article was posted by Enterprise Leader and is owned by of Enterprise Leader. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://theenterpriseleader.com/2019/01/14/clorox-co-clx-shares-sold-by-cozad-asset-management-inc.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.